💪 Good at identifying strategic positioning angles - spotted FDA regulatory fear as broader market opportunity beyond UCB
🎯 Need to translate UCB insights into repeatable playbook for other pharma targets with same FDA fear
💪 Strong buy-in on revenue acceleration docs (90%+ agreement). Already mobilized Usaid to implement CRM changes. Proactive on near-term deal progression (UCB, Pfizer, Merck).
🎯 Shared Pfizer draft with champion before integrating Daniel's feedback - process gap. Pipeline reporting history shows past disconnect between board numbers and reality (acknowledged this is fixed now
💪 Strong relationship building - got Jan to confirm budget directly, extracted non-public drug adherence data in casual coffee conversation, asked the right 'gasoline on fire' question
🎯 Conversion/UX planning needs more proactive internal work before next client touchpoint